Tag Archives: BMTI

Medtronic (NYSE:MDT) Posts Lower Profits on Higher Legal and Other Outlays – BSX, STJ, ARNA, JNJ, DVAX, MRK, PFE, BMTI

Posted on November 20, 2012 by Thomas Vedder

Medtronic, Inc (NYSE:MDT) on Tuesday posted a lower quarterly earnings as legal and other outlays ate into profits.

The medical technology company announced net earnings were $646 million or 63 cents a share in fiscal second quarter finished Oct 26, …

Posted in Healthcare, Latest Headlines | Tagged Arena Pharmaceuticals, ARNA, BioMimetic Therapeutics, BMTI, Boston Scientific, BSX, DVAX, Dynavax Technologies, JNJ, Johnson & Johnson, MDT, Medtronic, Merck, MRK, NASDAQ:ARNA, NASDAQ:BMTI, NASDAQ:DVAX, NYSE:BSX, NYSE:JNJ, NYSE:MDT, NYSE:MRK, NYSE:PFE, NYSE:STJ, PFE, Pfizer, St. Jude Medical, STJ | Comments Off

Healthcare Sector Shows Bearish Weekly Performance; Questcor (QCOR) Unveils New Dividend Plan & Lifts Buyback while Cytori (CYTX) Hikes After Govt. Contract – QCOR, CYTX, JNJ, BMTI, CRY

Posted on October 1, 2012 by Thomas Vedder

Last trading session’s data showed that healthcare sector reacted negatively with -0.51% change. BioMimetic Therapeutics, Inc. (NASDAQ:BMTI) and Cryolife Inc. (NYSE:CRY) were major percentage decliners in this sector while most active stock was Johnson & Johnson (NYSE:JNJ).

Questcor Pharmaceuticals, Inc. …

Posted in Healthcare, Latest Headlines | Tagged BioMimetic Therapeutics, BMTI, CRY, Cryolife, Cytori, CYTX, JNJ, Johnson, NASDAQ:BMTI, NASDAQ:CYTX, NASDAQ:QCOR, NYSE:CRY, NYSE:JNJ, QCOR, Questcor | Comments Off

BioMimetic Therapeutics (NASDAQ:BMTI) Provides More Data to FDA – BMTI, ZMH, SYK, JNJ

Posted on July 10, 2012 by Geoff Noir

The Franklin, Tennessee-based BioMimetic Therapeutics, Inc (NASDAQ:BMTI) reported on Monday that it submitted more data sought by health regulators for the marketing support of the corporation’s bone graft product, sending its shares high 14% after the bell.

The biotechnology corporation …

Posted in Healthcare, Latest Headlines | Tagged BioMimetic, BMTI, JNJ, Johnson, NASDAQ:BMTI, NYSE:JNJ, NYSE:SYK, NYSE:ZMH, Stryker, SYK, Zimmer, ZMH | Comments Off

What the fuss AutoNation, BioMimetic Therapeutics and LCA-Vision?

Posted on January 4, 2012 by Cameron White

In this report: AutoNation (NYSE:AN), BioMimetic Therapeutics (NASDAQ:BMTI) and LCA-Vision (NASDAQ:LCAV).

AutoNation (NYSE:AN) shares dropped by more than 6 percent on Wednesday after it was reported that a group of hedge funds led by Edward Lampert’s ESL Partners LP has …

Posted in Main Post, Reports | Tagged AN, Augment, AutoNation, BioMimetic Therapeutics, BMTI, clinical, FDA, Food & Drug Administration, hedge fund, investors, LCA-Vision, LCAV, NASDAQ, NASDAQ:BMTI, NASDAQ:LCAV, net income, NYSE, NYSE:AN, outstanding, reported, shares, stake | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.